Tokuda Y - Search Results

1

Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.

Umemura S, Takekoshi S, Suzuki Y, Saitoh Y, Tokuda Y, Osamura RY. Umemura S, et al. Among authors: tokuda y. Oncol Rep. 2005 Aug;14(2):337-43. Oncol Rep. 2005. PMID: 16012712

2

Immunohistochemical evaluation of hormone receptor for routine practice of breast cancer: highly sensitive procedures significantly contribute to the correlation with biochemical assays.

Umemura S, Itoh H, Ohta M, Suzuki Y, Kubota M, Tokuda Y, Tajima T, Osamura RY. Umemura S, et al. Among authors: tokuda y. Appl Immunohistochem Mol Morphol. 2003 Mar;11(1):62-72. doi: 10.1097/00129039-200303000-00011. Appl Immunohistochem Mol Morphol. 2003. PMID: 12610359

3

Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation.

Sekido Y, Umemura S, Takekoshi S, Suzuki Y, Tokuda Y, Tajima T, Osamura RY. Sekido Y, et al. Among authors: tokuda y. Int J Oncol. 2003 Jun;22(6):1225-32. Int J Oncol. 2003. PMID: 12738987

4

Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures?

Umemura S, Itoh J, Itoh H, Serizawa A, Saito Y, Suzuki Y, Tokuda Y, Tajima T, Osamura RY. Umemura S, et al. Among authors: tokuda y. Appl Immunohistochem Mol Morphol. 2004 Mar;12(1):8-13. doi: 10.1097/00129039-200403000-00002. Appl Immunohistochem Mol Morphol. 2004. PMID: 15163012

5

Clinicopathological correlation between expression of PTHrP receptor and various prognostic factors in breast cancer without axillary lymph node metastasis.

Suzuki Y, Tokuda Y, Saito Y, Umemura S, Osamura RY. Suzuki Y, et al. Among authors: tokuda y. Tokai J Exp Clin Med. 2005 Jul;30(2):127-32. Tokai J Exp Clin Med. 2005. PMID: 16146204

6

Increased phosphorylation of Akt in triple-negative breast cancers.

Umemura S, Yoshida S, Ohta Y, Naito K, Osamura RY, Tokuda Y. Umemura S, et al. Among authors: tokuda y. Cancer Sci. 2007 Dec;98(12):1889-92. doi: 10.1111/j.1349-7006.2007.00622.x. Epub 2007 Sep 24. Cancer Sci. 2007. PMID: 17892507 Free article.

7

Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer.

Tang XY, Umemura S, Tsukamoto H, Kumaki N, Tokuda Y, Osamura RY. Tang XY, et al. Among authors: tokuda y. Pathol Res Pract. 2010 Feb 15;206(2):98-101. doi: 10.1016/j.prp.2009.06.010. Epub 2009 Jul 15. Pathol Res Pract. 2010. PMID: 19608352

8

Alteration of immunohistochemical biomarkers between pre- and post-chemotherapy: hormone receptors, HER2 and Ki-67.

Kumaki N, Umemura S, Tang X, Saito Y, Suzuki Y, Tokuda Y. Kumaki N, et al. Among authors: tokuda y. Breast Cancer. 2011 Apr;18(2):98-102. doi: 10.1007/s12282-010-0238-1. Epub 2011 Feb 3. Breast Cancer. 2011. PMID: 21290265 Review.

9

High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers.

Umemura S, Shirane M, Takekoshi S, Tokuda Y, Mori K, Osamura RY. Umemura S, et al. Among authors: tokuda y. Oncol Lett. 2010 Mar;1(2):261-266. doi: 10.3892/ol_00000046. Epub 2010 Mar 1. Oncol Lett. 2010. PMID: 22966291 Free PMC article.

10

[Breast cancer].

Tokuda Y, Saito Y, Suzuki Y, Ohta M, Tajima T. Tokuda Y, et al. Nihon Rinsho. 2002 Mar;60(3):563-9. Nihon Rinsho. 2002. PMID: 11904974 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

978 results

Search Page